Range
1.37 - 1.45
Vol / Avg.
126.9K/1.4M
Div / Yield
-
52 Wk
0.55 - 5.15
Mkt Cap
48.6M
Payout Ratio
-
Open
1.38
P/E
-
EPS
-4.62
Shares
34.7M
Outstanding
34.7M
Total Float
-
Sector: Health Care.Industry: Biotechnology
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).

Related Companies

TickerCompanyChg %Mkt Cap
ATHEAlterity Therapeutics0%48.6M

Alterity Therapeutics Frequently Asked Questions

Q

How do I buy Alterity Therapeutics (ATHE) stock?

A

You can purchase shares of Alterity Therapeutics (NASDAQ: ATHE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Alterity Therapeutics's (ATHE) competitors?

Q

What is the target price for Alterity Therapeutics (ATHE) stock?

A

There is no analysis for Alterity Therapeutics

Q

Current Stock Price for Alterity Therapeutics (ATHE)?

A

The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $1.4 last updated Thu Jun 17 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Alterity Therapeutics (ATHE) pay a dividend?

A

There are no upcoming dividends for Alterity Therapeutics.

Q

When is Alterity Therapeutics (NASDAQ:ATHE) reporting earnings?

A

Alterity Therapeutics does not have any upcoming earnings scheduled.

Q

Is Alterity Therapeutics (ATHE) going to split?

A

There is no upcoming split for Alterity Therapeutics.

Q

What sector and industry does Alterity Therapeutics (ATHE) operate in?

A

Alterity Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.